肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

真性红细胞增多症中动脉血栓与静脉血栓的危险因素:587例单中心经验

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

原文发布日期:2017-12-27

DOI: 10.1038/s41408-017-0035-6

类型: Article

开放获取: 是

英文摘要:

摘要翻译: 

原文链接:

文章:

真性红细胞增多症中动脉血栓与静脉血栓的危险因素:587例单中心经验

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

原文发布日期:2017-12-27

DOI: 10.1038/s41408-017-0035-6

类型: Article

开放获取: 是

 

英文摘要:

In a recent International Working Group on Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) study, prior arterial events and hypertension were predictors of subsequent arterial thrombosis whereas prior venous events and age ≥65 years predicted venous thrombosis in polycythemia vera (PV). In the current study, we sought to validate the above findings and identify additional predictors of arterial versus venous thrombosis. At a median follow up of 109 months, thrombosis after diagnosis occurred in 128 (22%) patients; 82 (14%) arterial and 57 (10%) venous events. On multivariate analysis, prior arterial events (<0.0001), hyperlipidemia (p = 0.03), and hypertension (p = 0.02) predicted subsequent arterial events. In comparison, prior venous events (p = 0.05), leukocytosis ≥11 × 109/L (p = 0.002), and major hemorrhage (p = 0.02) were predictors of subsequent venous events. Salient associations with arterial thrombosis included age ≥ 60 years, hypertension, diabetes, hyperlipidemia and normal karyotype whereas age ≤ 60 years, females, palpable splenomegaly and history of major hemorrhage were associated with venous thrombosis. TET2 or ASXL1 mutations did not impact arterial nor venous thrombosis. In conclusion, we identify distinct associations for arterial versus venous thrombosis in PV and confirm that a prior arterial or venous thrombotic event is the most reliable predictor of subsequent events.

 

摘要翻译: 

最近一项由骨髓增殖性肿瘤研究与治疗国际工作组开展的研究表明,在真性红细胞增多症患者中,先前的动脉事件和高血压是后续动脉血栓形成的预测因素,而既往静脉事件和年龄≥65岁则预测静脉血栓形成。本研究旨在验证上述发现,并识别动脉与静脉血栓的其他预测因子。在中位随访109个月时,128例(22%)患者确诊后出现血栓形成,其中动脉事件82例(14%),静脉事件57例(10%)。多变量分析显示,既往动脉事件(p<0.0001)、高脂血症(p=0.03)和高血压(p=0.02)可预测后续动脉事件;而既往静脉事件(p=0.05)、白细胞计数≥11×10⁹/L(p=0.002)及大出血(p=0.02)是后续静脉事件的预测因子。与动脉血栓形成显著相关的因素包括年龄≥60岁、高血压、糖尿病、高脂血症及正常核型;而与静脉血栓形成相关的因素包括年龄≤60岁、女性、可触及脾肿大和大出血史。TET2或ASXL1突变对动脉或静脉血栓形成均无影响。本研究明确了真性红细胞增多症中动脉与静脉血栓形成的不同关联因素,并证实既往动静脉血栓事件是后续事件最可靠的预测指标。

 

原文链接:

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……